These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17042418)

  • 1. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA; Carr RM
    WMJ; 2006 Sep; 105(6):36-9. PubMed ID: 17042418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients.
    Burns ME; Fiore MC
    WMJ; 2001; 100(3):54-8. PubMed ID: 11491035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Watching the monitors: "PAID" prescriptions, fiscal intermediaries and drug-utilization review.
    Morgan JP
    N Engl J Med; 1977 Feb; 296(5):251-6. PubMed ID: 318733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
    Chen H; Deshpande AD; Jiang R; Martin BC
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
    J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Break-even analysis of Medicaid vs fee for service in orthodontic practice: North Carolina as a case study.
    Murdock JE; Phillips C; Beane R; Quinonez R
    Am J Orthod Dentofacial Orthop; 2010 Mar; 137(3):334-9. PubMed ID: 20197169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining physicians' knowledge and attitudes when prescribing drugs to treat gastrointestinal disorders.
    Soons KR; Lynch T; Seagrave M; Rolley L
    Clin Perform Qual Health Care; 1997; 5(2):94-8. PubMed ID: 10167220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Medicaid database to analyze pharmaceutical services in long-term-care facilities.
    Lipowski EE; Wiederholt JB; Kreling DH; Collins TM
    Am J Hosp Pharm; 1986 Jun; 43(6):1467-72. PubMed ID: 3088992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug prescription and utilization in Morocco].
    Simon N; Hakkou F; Minani M; Jasson M; Diquet B
    Therapie; 1998; 53(2):113-20. PubMed ID: 9773110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.